How AbbVie and BusinessOptix are building visibility, agility, and readiness for AI-driven transformation.

AI is reshaping the way organizations approach operational excellence, but real success depends on what comes first: building the foundation. In this fireside chat, Joy Shelledy, Director, Strategic Change Enablement, AbbVie; Amanda Swearengen, Director II, Strategic Change Enablement, AbbVie and Jeff Alker, Solutions Consultant, BusinessOptix, will explore how life sciences leaders can map and model processes to create end-to-end visibility, test scenarios before committing to automation, and establish ROI long before bots or AI are deployed.

The discussion will highlight AbbVie’s journey, in documenting their end-to-end clinical trial processes leveraging the BusinessOptix platform and how this sets them up for the next wave of innovation. Beyond technology, the speakers will address the human side of transformation, including organizational agility, change management and sustaining impact across the enterprise.

• Why foundational process mapping and simulation are essential before committing to a process improvement
• How to apply a “try before you buy” approach to validate ROI and reduce transformation risk
• The role of organizational agility and change management in sustaining transformation success
• How leaders can set the stage today for long-term impact from AI and digital transformation initiatives